| Oct 22 |
AbbVie: Strong Dividends But Humira Disappoints
|
| Oct 22 |
The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and Sanofi
|
| Oct 21 |
Nine Provinces Approve Accelerated Public Reimbursement of Diffuse Large B-Cell Lymphoma Treatment Under New Early Access Process
|
| Oct 20 |
Allergan’s BOTOX Cosmetic gets FDA approval in jaw-neck bands
|
| Oct 19 |
AbbVie says latest FDA approval expands Botox use beyond face
|
| Oct 18 |
BOTOX® Cosmetic (onabotulinumtoxinA) Receives FDA Approval for Moderate to Severe Vertical Bands Connecting the Jaw and Neck (Platysma Bands)
|
| Oct 18 |
AbbVie (ABBV): Growth Driven by Skyrizi, Rinvoq, and Strategic Acquisitions
|
| Oct 18 |
FDA Approves AbbVie's VYALEV as First 24-Hour Levodopa Infusion for Advanced Parkinson's
|
| Oct 18 |
Pharma Stock Roundup: JNJ's Q3 Earnings, FDA Nod to Some New Drugs
|
| Oct 18 |
Analysts revise AbbVie stock price target ahead of earnings
|
